The work of the Diagnostic & Therapeutic Technologies Research Group (D&TT) group aims to utilise Biomedical Engineering to improve rapid clinical diagnostic technologies and to engineer technological approaches which can help to elucidate the molecular pathways that cause degenerative diseases. This work involves the design and development of highly specific 'bioelectronic' interfaces between inorganic surfaces and biological species (antibodies, microbial cells, enzymes and redox proteins) and has led to the production of a number of electrochemical and microelectromechanical sensor systems capable of the direct, rapid measurement of biological and chemical species in complex matrices. The current research programmes being carried out by the D&TT group can be broadly defined in three inter-related, multi-disciplinary areas. These are:
Our work has been highlighted in a number of public engagement and outreach activities including producing news items and videos aimed at public education of the D&TT vision of successful outcomes of collaborative multi-disciplinary research and also using social media to highlight achievements.
Current Major Research Funding
The Multi-Corder: EPSRC Programme Grant (£3.4M, May 2013 - Oct 2017).
Early-Warning Sensing Systems for Infectious Diseases (i-sense): EPSRC IRC (£11.1M, Oct 2013 - Sept 2018).
Personal Risk Assessment in Febrile Illness to Optimize Real-life Management Across the EU (PERFORM): EC H2020 (Jan 2016 - Dec 2020).
This research is funded by the European Commission Framework 7 Programme.
This research is funded by the Engineering and Physical Sciences Research Council.